AI Portfolio Summary
In 2025 Q4, Bellevue Group AG maintained a portfolio of 185 distinct positions. The most significant new addition to the portfolio was AMICUS THERAPEUTICS , which now represents 2.90% of the total fund value. They heavily accumulated shares in VERTEX PHARMACEUTICA, increasing their position by 34.7%. The fund also reduced its exposure to WAVE LIFE SCIENCES L by 63.6%.
Total Positions
185
Quarter
2025 Q4
Top Holding
RVMD (7.6%)
Top 10 Concentration
49.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 185
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 7.56% | 5.41% |
#1
2
Prev: #3
|
5.5 | -568,119 | -10.2% |
P
S
|
5,005,719 | $398,705,518 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARGX
ARGENX SE
|
Healthcare | 7.36% | 8.37% |
#2
Prev: #2
|
4.9 | -84,474 | -15.5% |
P
S
|
461,854 | $388,396,121 | 2018 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 7.20% | 8.49% |
#3
2
Prev: #1
|
3.9 | -1,442,252 | -23.1% |
P
S
|
4,802,199 | $379,901,963 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRTX
VERTEX PHARMACE...
|
Healthcare | 5.85% | 4.12% |
#4
2
Prev: #6
|
5.3 | 175,315 | 34.7% |
P
S
|
681,120 | $308,792,563 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 4.58% | 5.14% |
#5
1
Prev: #4
|
2.8 | -59,801 | -3.4% |
P
S
|
1,703,304 | $241,579,606 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RNA
AVIDITY BIOSCIE...
|
Healthcare | 3.60% | 1.95% |
#6
10
Prev: #16
|
3.9 | 478,107 | 22.2% |
P
S
|
2,630,969 | $189,771,794 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 3.46% | 3.24% |
#7
3
Prev: #10
|
1.9 | -26,598 | -7.6% |
P
S
|
322,028 | $182,383,778 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 3.39% | 2.51% |
#8
5
Prev: #13
|
3.9 | 812,055 | 25.0% |
P
S
|
4,056,592 | $178,692,878 | 2019 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALNY
ALNYLAM PHARMAC...
|
Healthcare | 3.36% | 4.23% |
#9
4
Prev: #5
|
1.8 | -621 | -0.1% |
P
S
|
445,903 | $177,313,328 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABT
ABBOTT LABS
|
Healthcare | 3.13% | 4.11% |
#10
3
Prev: #7
|
1.8 | -161,648 | -10.9% |
P
S
|
1,316,915 | $164,996,280 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FOLD
AMICUS THERAPEU...
|
Healthcare | 2.90% | — |
#11
Prev: #—
|
4.7 | 10,735,195 | no change |
NEW
|
10,735,195 | $152,869,177 | 2019 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 2.82% | 3.37% |
#12
3
Prev: #9
|
1.6 | -100,243 | -6.0% |
P
S
|
1,559,606 | $148,708,432 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 2.57% | — |
#13
Prev: #—
|
4.5 | 4,358,527 | no change |
NEW
|
4,358,527 | $135,637,360 | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SYK
STRYKER CORPORA...
|
Healthcare | 2.40% | 3.46% |
#14
6
Prev: #8
|
1.0 | -90,519 | -20.1% |
P
S
|
360,577 | $126,731,999 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NUVL
NUVALENT INC
|
Healthcare | 1.98% | — |
#15
Prev: #—
|
4.3 | 1,037,468 | no change |
NEW
|
1,037,468 | $104,358,906 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 1.92% | 0.00% |
#16
116
Prev: #132
|
3.8 | 409,011 | 31174.6% |
P
S
|
410,323 | $101,161,033 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 1.86% | 1.91% |
#17
Prev: #17
|
1.2 | 60,000 | 1.7% |
P
S
|
3,617,669 | $98,255,890 | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 1.84% | 2.11% |
#18
3
Prev: #15
|
1.7 | no change | no change |
P
S
|
2,796,803 | $97,077,032 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EW
EDWARDS LIFESCI...
|
Healthcare | 1.69% | 1.45% |
#19
1
Prev: #20
|
2.7 | 146,463 | 16.3% |
P
S
|
1,043,096 | $88,923,935 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 1.63% | — |
#20
Prev: #—
|
4.2 | 1,698,152 | no change |
NEW
|
1,698,152 | $85,994,417 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MDT
MEDTRONIC PLC
|
Healthcare | 1.40% | 1.50% |
#21
3
Prev: #18
|
1.1 | 6,731 | 0.9% |
P
S
|
766,592 | $73,638,828 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 1.34% | 0.91% |
#22
7
Prev: #29
|
1.0 | -246 | -0.0% |
P
S
|
8,345,364 | $70,601,779 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IDXX
IDEXX LABS INC
|
Healthcare | 1.21% | 1.02% |
#23
3
Prev: #26
|
3.0 | 17,952 | 23.4% |
P
S
|
94,539 | $63,958,470 | 2018 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 1.10% | 1.22% |
#24
2
Prev: #22
|
0.9 | 5,112 | 3.0% |
P
S
|
175,169 | $57,825,039 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DXCM
DEXCOM INC
|
Healthcare | 1.07% | 1.10% |
#25
1
Prev: #24
|
2.4 | 61,287 | 7.8% |
P
S
|
847,405 | $56,242,270 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PODD
INSULET CORP
|
Healthcare | 1.01% | 1.36% |
#26
5
Prev: #21
|
0.9 | -25,306 | -11.9% |
P
S
|
186,699 | $53,067,324 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BDX
BECTON DICKINSO...
|
Healthcare | 0.98% | 1.15% |
#27
4
Prev: #23
|
0.9 | -31,232 | -10.5% |
P
S
|
265,662 | $51,557,024 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JBIO
JADE BIOSCIENCE...
|
Healthcare | 0.98% | — |
#28
Prev: #—
|
3.9 | 3,341,103 | no change |
NEW
|
3,341,103 | $51,553,219 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DHR
DANAHER CORPORA...
|
Healthcare | 0.84% | 0.68% |
#29
7
Prev: #36
|
2.3 | 30,757 | 18.8% |
P
S
|
194,633 | $44,555,386 | 2016 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PEN
PENUMBRA INC
|
Healthcare | 0.80% | 0.77% |
#30
2
Prev: #32
|
0.8 | -11,500 | -7.8% |
P
S
|
135,395 | $42,095,659 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RMD
RESMED INC
|
Healthcare | 0.74% | 0.94% |
#31
4
Prev: #27
|
0.8 | -3,620 | -2.2% |
P
S
|
161,214 | $38,831,616 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 0.72% | 0.94% |
#32
4
Prev: #28
|
0.3 | -1,247,479 | -44.9% |
P
S
|
1,528,518 | $37,930,174 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TMO
THERMO FISHER S...
|
Healthcare | 0.71% | 1.07% |
#33
8
Prev: #25
|
0.3 | -41,108 | -38.7% |
P
S
|
65,077 | $37,708,868 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 0.70% | — |
#34
Prev: #—
|
3.8 | 887,708 | no change |
NEW
|
887,708 | $36,777,742 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 0.69% | 0.64% |
#35
2
Prev: #37
|
0.8 | -6,511 | -16.1% |
P
S
|
34,003 | $36,542,344 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GEHC
GE HEALTHCARE T...
|
Healthcare | 0.66% | 0.72% |
#36
2
Prev: #34
|
0.8 | -38,549 | -8.3% |
P
S
|
424,514 | $34,818,638 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 0.66% | — |
#37
Prev: #—
|
3.8 | 3,927,670 | no change |
NEW
|
3,927,670 | $34,799,156 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABBV
ABBVIE INC
|
Healthcare | 0.58% | 0.82% |
#38
7
Prev: #31
|
0.2 | -36,011 | -21.1% |
P
S
|
134,859 | $30,813,932 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CI
THE CIGNA GROUP
|
Healthcare | 0.57% | 0.73% |
#39
6
Prev: #33
|
0.7 | -12,473 | -10.2% |
P
S
|
110,013 | $30,278,878 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GKOS
GLAUKOS CORP
|
Healthcare | 0.56% | 0.09% |
#40
37
Prev: #77
|
3.2 | 206,009 | 368.4% |
P
S
|
261,935 | $29,575,081 | 2016 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JNJ
JOHNSON & JOHNS...
|
Healthcare | 0.50% | 0.29% |
#41
16
Prev: #57
|
3.2 | 51,993 | 69.5% |
P
S
|
126,800 | $26,241,260 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ANNX
ANNEXON INC
|
Healthcare | 0.49% | 0.33% |
#42
11
Prev: #53
|
1.2 | no change | no change |
P
S
|
5,157,290 | $25,889,596 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
STE
STERIS PLC
|
Healthcare | 0.49% | 0.61% |
#43
3
Prev: #40
|
0.7 | -16,407 | -13.9% |
P
S
|
101,705 | $25,784,252 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WVE
WAVE LIFE SCIEN...
|
Healthcare | 0.48% | 0.62% |
#44
6
Prev: #38
|
0.2 | -2,603,940 | -63.6% |
P
S
|
1,490,518 | $25,338,806 | 2019 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ELV
ELEVANCE HEALTH...
|
Healthcare | 0.46% | 0.70% |
#45
10
Prev: #35
|
0.2 | -35,326 | -33.7% |
P
S
|
69,645 | $24,414,055 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COO
COOPER COS INC
|
Healthcare | 0.45% | 0.42% |
#46
2
Prev: #44
|
0.7 | -306 | -0.1% |
P
S
|
291,959 | $23,928,960 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GMED
GLOBUS MED INC
|
Healthcare | 0.43% | 0.39% |
#47
1
Prev: #46
|
0.7 | -64,184 | -19.6% |
P
S
|
262,683 | $22,934,853 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALGN
ALIGN TECHNOLOG...
|
Healthcare | 0.42% | 0.38% |
#48
1
Prev: #47
|
0.7 | -3,202 | -2.2% |
P
S
|
141,474 | $22,091,165 | 2017 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZBH
ZIMMER BIOMET H...
|
Healthcare | 0.41% | 0.50% |
#49
6
Prev: #43
|
0.7 | -6,522 | -2.7% |
P
S
|
238,680 | $21,462,106 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MCK
MCKESSON CORP
|
Healthcare | 0.39% | 0.61% |
#50
11
Prev: #39
|
0.2 | -12,859 | -33.9% |
P
S
|
25,098 | $20,587,639 | 2016 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-50 of 185 holdings